iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma.

Liu, Qinhua; Dai, Guanrong; Wu, Yi; Zhang, Mingxia; Yang, Mingya; Wang, Xiaonan; Song, Mingyue; Li, Xiaodan; Xia, Ruixiang; Wu, Zhengsheng

Liu, Qinhua; Dai, Guanrong; Wu, Yi; Zhang, Mingxia; Yang, Mingya; Wang, Xiaonan; Song, Mingyue; Li, Xiaodan; Xia, Ruixiang; Wu, Zhengsheng.

Afiliación

Liu Q; Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Dai G; Department of Intensive Care Unit, Nantong First People's Hospital, Nantong, China.
Wu Y; Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Zhang M; Department of Radiotherapy, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yang M; Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Wang X; Laboratory of Pathogenic Microbiology and Immunology, Anhui Medical University, Hefei, China.
Song M; Department of Hematology, The Chaohu Hospital Affiliated to Anhui Medical University, Chaohu, China.
Li X; Department of Intensive Care Unit, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Xia R; Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Wu Z; Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Front Oncol ; 12: 822805, 2022.

Article en En | MEDLINE | ID: mdl-35982974

Palabras clave

BCL6; delivery vehicle; diffuse large B-cell lymphoma; exosomes; small interfering RNA

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google